RecensMedical, Inc. (KOSDAQ:394420)

Market Cap	124.78B
Revenue (ttm)	7.60B +31.7%
Net Income	-17.38B
EPS	-2,149.91
Shares Out	10.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,356
Open	11,960
Previous Close	12,080
Day's Range	10,550 - 11,960
52-Week Range	10,550 - 39,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394420

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 21, 2026

Data Sources Report a data error